The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 19, 2016

Filed:

May. 20, 2014
Applicants:

Abbvie Deutschland Gmbh & Co. KG, Wiesbaden, DE;

Abbott Laboratories, Abbott Park, IL (US);

Inventors:

Frauke Pohlki, Wiesbaden, DE;

Udo Lange, Wiesbaden, DE;

Wilhelm Amberg, Wiesbaden, DE;

Michael Ochse, Wiesbaden, DE;

Berthold Behl, Wiesbaden, DE;

Wilfried Hornberger, Wiesbaden, DE;

Mario Mezler, Wiesbaden, DE;

Charles W. Hutchins, Green Oaks, IL (US);

Sean Turner, Wiesbaden, DE;

Assignees:

AbbVie Deutschland GmbH & Co. KG, Wiesbaden, DE;

AbbVie Inc., North Chicago, IL (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/135 (2006.01); C07C 211/25 (2006.01); C07C 311/06 (2006.01); C07C 311/04 (2006.01); C07C 311/05 (2006.01); C07C 311/10 (2006.01); C07D 205/04 (2006.01); C07D 207/08 (2006.01); C07D 207/267 (2006.01); C07D 231/18 (2006.01); C07D 233/42 (2006.01); C07D 295/135 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 233/84 (2006.01);
U.S. Cl.
CPC ...
C07C 311/06 (2013.01); C07C 311/04 (2013.01); C07C 311/05 (2013.01); C07C 311/10 (2013.01); C07D 205/04 (2013.01); C07D 207/08 (2013.01); C07D 207/267 (2013.01); C07D 231/18 (2013.01); C07D 233/42 (2013.01); C07D 233/84 (2013.01); C07D 295/135 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07C 2101/02 (2013.01); C07C 2101/04 (2013.01);
Abstract

The present invention relates to phenalkylamine derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such phenalkylamine derivatives, and the use of such phenalkylamine derivatives for therapeutic purposes. The phenalkylamine derivatives are GlyT1 inhibitors.


Find Patent Forward Citations

Loading…